This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Graves, D C Articles by Worley, M A Search for Related Content PubMed PubMed Citation Articles by Graves, D C Articles by Worley, M A

Development and characterization of monoclonal antibodies to Pneumocystis carinii.

ABSTRACT

Hybridoma-producing monoclonal antibodies against Pneumocystis carinii were produced by the fusion of nonsecreting mouse myeloma cells (P3X63-Ag8.653) with splenocytes from BALB/c mice that had been immunized with partially purified preparations of P. carinii. Of 227 hybridoma clones producing antibodies against P. carinii, as measured by an enzyme-linked immunosorbent assay, 12 monoclonal antibodies showing the highest reactivity in the enzyme-linked immunosorbent assay were further characterized. The majority (11 of 12) of the monoclonal antibodies did not cross-react with Candida albicans, Cryptococcus neoformans, Histoplasma capsulatum, or Mycobacterium avium as determined by absorption experiments. By using the indirect immunofluorescence assay, serological reactivity was shown for these antibodies with titers ranging from 1:40 to 1:10,240. By using a competitive binding assay, these 12 monoclonal antibodies could be divided into seven groups, each group reacting with a different antigenic determinant of P. carinii. Sodium dodecyl sulfate-polyacrylamide gradient gel electrophoresis of P. carinii, followed by Western immunoblot analysis, allowed the identification of one major antigen with an apparent molecular weight of 110,000 by all 12 monoclonal antibodies. Other minor bands with molecular weights of approximately 116,000, 90,000, 55,000, and 35,000 were recognized by several of the monoclonal antibodies.

This article has been cited by other articles:

• Wells, J., Gigliotti, F., Simpson-Haidaris, P. J., Haidaris, C. G. (2004). Epitope Mapping of a Protective Monoclonal Antibody against Pneumocystis carinii with Shared Reactivity to Streptococcus pneumoniae Surface Antigen PspA. Infect. Immun. 72: 1548-1556 [Abstract] [Full Text]  
• Gigliotti, F., Wiley, J. A., Harmsen, A. G. (1998). Immunization with Pneumocystis carinii gpA Is Immunogenic but Not Protective in a Mouse Model of P. carinii Pneumonia. Infect. Immun. 66: 3179-3182 [Abstract] [Full Text]  
• Linke, M. J., Sunkin, S. M., Andrews, R. P., Stringer, J. R., Walzer, P. D. (1998). Expression, Structure, and Location of Epitopes of the Major Surface Glycoprotein of Pneumocystis carinii f. sp. carinii. CVI 5: 50-57 [Abstract] [Full Text]  
• Kaneshiro, E. S. (1998). The Lipids of Pneumocystis carinii. Clin. Microbiol. Rev. 11: 27-41 [Abstract] [Full Text]